Retatrutide
Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
$27.90
$30.00Dosage Summary: 3 x $27.90
For laboratory research use only. Not intended for human consumption.
Molecular Formula
C221H342N46O68
Purity
=>99.4%
Storage
-20°C
Half Life
6 days
About Retatrutide
Retatrutide (originally known as LY-3437943) is a highly effective, investigative multi-receptor agonist developed for the treatment of severe obesity and type 2 diabetes. By simultaneously activating the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R), it works comprehensively to suppress appetite, enhance feelings of fullness, delay gastric emptying, and significantly increase energy expenditure. Clinical data indicates it provides substantial weight reduction profiles and highly robust glycemic control compared to earlier single or dual-receptor therapies.
Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
Store in a cool, dry environment: -20°C.
Browse more Weight Loss Peptides research peptides from Vylix Research Peptides.
Certificate Of Analysis
Every batch undergoes rigorous third-party analytical testing to confirm purity, identity, and consistency standards.
Download COARetatrutide Research Information
What is Retatrutide?
Retatrutide is a research compound supplied for laboratory analytical studies and scientific investigation.
Does Retatrutide include quality documentation?
Available documentation includes product specifications and batch-related analytical information where applicable.